Campbell Bradley L (CIK 1400971) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-27). Recent activity: Sell FOLD (1.0M shares), Sell FOLD (22,500 shares), Buy FOLD (75,000 shares), Sell FOLD (75,000 shares), Sell FOLD (108,602 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-27 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Sell | 1.0M | $14.6M |
| 2026-03-04 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Sell | 22,500 | $322,875 |
| 2026-01-22 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Buy | 75,000 | $457,500 |
| 2026-01-22 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Sell | 75,000 | $1.1M |
| 2025-12-30 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Sell | 108,602 | $1.5M |
| 2025-12-17 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Buy | 70,426 | $635,947 |
| 2025-12-17 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Sell | 77,926 | $846,276 |
| 2025-12-03 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Buy | 14,587 | $131,721 |
| 2025-12-03 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Sell | 14,587 | $146,016 |
| 2025-11-26 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Buy | 14,587 | $131,721 |
| 2025-11-26 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Sell | 14,587 | $146,453 |
| 2025-03-18 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Sell | 13,375 | $119,038 |
| 2025-02-21 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Buy | 400 | $3,612 |
| 2025-02-21 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Sell | 400 | $4,000 |
| 2025-02-13 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Buy | 137,075 | $0 |
| 2025-02-13 | AMICUS THERAPEUTICS, INC. (FOLD) | President and CEO | Sell | 70,711 | $676,704 |
Source: SEC Form 4 filings · as of 2026-04-27